Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 9.71 CNY -1.32% Market Closed
Market Cap: 4.3B CNY
Hunan Fangsheng Pharmaceutical Co Ltd
/
Income Statement
/
Revenue

Hunan Fangsheng Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hunan Fangsheng Pharmaceutical Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Revenue
¥1.8B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
16%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥12.3B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥10.9B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥28B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
14%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
¥2B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Revenue
¥5.8B
CAGR 3-Years
94%
CAGR 5-Years
37%
CAGR 10-Years
N/A

Hunan Fangsheng Pharmaceutical Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Pharmaceuticals

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.

Intrinsic Value
15.07 CNY
Undervaluation 36%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Hunan Fangsheng Pharmaceutical Co Ltd's Revenue?
Revenue
1.8B CNY

Based on the financial report for Sep 30, 2024, Hunan Fangsheng Pharmaceutical Co Ltd's Revenue amounts to 1.8B CNY.

What is Hunan Fangsheng Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
16%

Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Hunan Fangsheng Pharmaceutical Co Ltd have been 6% over the past three years , 10% over the past five years , and 16% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 251,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.